Comparison of Adverse Maternal Outcomes between Early- and Late-Onset Superimposed Preeclampsia

 

 Buy Article Permissions and Reprints

Abstract

Objective Superimposed preeclampsia (SIPE), defined as preeclampsia in individuals with chronic hypertension, is one of the most common complications, accounting for 13 to 40% of pregnancies with chronic hypertension. However, there are limited data regarding maternal outcomes of early- and late-onset SIPE in individuals with chronic hypertension. We hypothesized that early-onset SIPE was associated with increased odds of adverse maternal outcomes compared with late-onset SIPE. Therefore, we aimed to compare adverse maternal outcomes between individuals with early-onset SIPE and those with late-onset SIPE.

Study Design This was a retrospective cohort study of pregnant individuals with SIPE who delivered at 22 weeks' gestation or greater at an academic institution. Early-onset SIPE was defined as the onset of SIPE before 34 weeks' gestation. Late-onset SIPE was defined as the onset of SIPE at or after 34 weeks' gestation. Our primary outcome was a composite of eclampsia, hemolysis, elevated liver enzymes, low platelet count (HELLP) syndrome, maternal death, placental abruption, pulmonary edema, SIPE with severe features, and thromboembolic disease. Maternal outcomes were compared between early- and late-onset SIPE. We used simple and multivariate logistic regression models to calculate crude and adjusted odds ratios (aOR) with 95% confidence intervals (95% CI).

Results Of 311 individuals, 157 (50.5%) had early-onset SIPE, 154 (49.5%) had late-onset SIPE. There were significant differences in the proportions of obstetric complications, including the primary outcome, HELLP syndrome, SIPE with severe features, fetal growth restriction (FGR), and cesarean delivery between early- and late-onset SIPE. Compared with individuals with late-onset SIPE, those with early-onset SIPE had increased odds of the primary outcome (aOR: 3.28; 95% CI: 1.42–7.59), SIPE with severe features (aOR: 2.72; 95% CI: 1.25–5.90), FGR (aOR: 6.07; 95% CI: 3.25–11.36), and cesarean delivery (aOR 3.42; 95% CI: 2.03–5.75).

Conclusion Individuals with early-onset SIPE had higher odds of adverse maternal outcomes compared with those with late-onset SIPE.

Key Points

• We revealed the incidence of maternal outcomes in early- and late-onset SIPE.

• Severe features were common in individuals with SIPE.

• Early-onset SIPE was associated with increased adverse maternal outcomes compared with late-onset SIPE.

Note

This study was presented as a poster presentation at the Society for Maternal-Fetal Medicine 43rd Annual Pregnancy Meeting (February 6–11, 2023).

Publication History

Received: 24 February 2023

Accepted: 18 May 2023

Accepted Manuscript online:
19 May 2023

Article published online:
19 June 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

• References

• 1 Bateman BT, Bansil P, Hernandez-Diaz S, Mhyre JM, Callaghan WM, Kuklina EV. Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol 2012; 206 (02) 134.e1-134.e8
  CrossrefPubMedGoogle Scholar
• 2 Sibai BM, Lindheimer M, Hauth J. et al; National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. N Engl J Med 1998; 339 (10) 667-671
  CrossrefPubMedGoogle Scholar
• 3 Ferrer RL, Sibai BM, Mulrow CD, Chiquette E, Stevens KR, Cornell J. Management of mild chronic hypertension during pregnancy: a review. Obstet Gynecol 2000; 96 (5 Pt 2): 849-860
  PubMedGoogle Scholar
• 4 American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 203: chronic hypertension in pregnancy. Obstet Gynecol 2019; 133 (01) e26-e50
  CrossrefPubMedGoogle Scholar
• 5 Chappell LC, Enye S, Seed P, Briley AL, Poston L, Shennan AH. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertension 2008; 51 (04) 1002-1009
  CrossrefPubMedGoogle Scholar
• 6 Wadhwani P, Saha PK, Kalra JK, Gainder S, Sundaram V. A study to compare maternal and perinatal outcome in early vs. late onset preeclampsia. Obstet Gynecol Sci 2020; 63 (03) 270-277
  CrossrefPubMedGoogle Scholar
• 7 Wertaschnigg D, Selvaratnam RJ, Rolnik DL. et al. Hypertensive disorders in pregnancy - Trends over eight years: a population-based cohort study. Pregnancy Hypertens 2022; 28: 60-65
  CrossrefPubMedGoogle Scholar
• 8 Kawakita T, Seagraves E, Baraki D, Donaldson T, Barake C, Abuhamad A. Assessment of baseline renal function tests to predict adverse outcomes in women with chronic hypertension. Am J Obstet Gynecol 2022; 228 (01) 95-97.E3
  CrossrefPubMedGoogle Scholar
• 9 Koopmans CM, Bijlenga D, Groen H. et al; HYPITAT study group. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 2009; 374 (9694): 979-988
  CrossrefPubMedGoogle Scholar
• 10 Zur RL, Kingdom JC, Parks WT, Hobson SR. The placental basis of fetal growth restriction. Obstet Gynecol Clin North Am 2020; 47 (01) 81-98
  CrossrefPubMedGoogle Scholar
• 11 Chau K, Hennessy A, Makris A. Placental growth factor and pre-eclampsia. J Hum Hypertens 2017; 31 (12) 782-786
  CrossrefPubMedGoogle Scholar
• 12 Agrawal S, Shinar S, Cerdeira AS, Redman C, Vatish M. Predictive performance of PlGF (placental growth factor) for screening preeclampsia in asymptomatic women: a systematic review and meta-analysis. Hypertension 2019; 74 (05) 1124-1135
  CrossrefPubMedGoogle Scholar
• 13 Catov JM, Ness RB, Kip KE, Olsen J. Risk of early or severe pre-eclampsia related to pre-existing conditions. Int J Epidemiol 2007; 36 (02) 412-419
  CrossrefPubMedGoogle Scholar
• 14 Ram M, Berger H, Geary M. et al; Diabetes, Obesity and Hypertension in Pregnancy Research Network (DOH-NET) and the Southern Ontario Obstetrical Network (SOON) Investigators. Timing of delivery in women with chronic hypertension. Obstet Gynecol 2018; 132 (03) 669-677
  CrossrefPubMedGoogle Scholar
• 15 Harper LM, Biggio JR, Anderson S, Tita ATN. Gestational age of delivery in pregnancies complicated by chronic hypertension. Obstet Gynecol 2016; 127 (06) 1101-1109
  CrossrefPubMedGoogle Scholar
• 16 Hutcheon JA, Lisonkova S, Magee LA. et al. Optimal timing of delivery in pregnancies with pre-existing hypertension. BJOG 2011; 118 (01) 49-54
  CrossrefPubMedGoogle Scholar
• 17 Tita AT, Szychowski JM, Boggess K. et al; Chronic Hypertension and Pregnancy (CHAP) Trial Consortium. Treatment for mild chronic hypertension during pregnancy. N Engl J Med 2022; 386 (19) 1781-1792
  CrossrefPubMedGoogle Scholar
• 18 Simard JF, Rossides M, Wikström AK, Falasinnu T, Palmsten K, Arkema EV. Evidence of under-reporting of early-onset preeclampsia using register data. Paediatr Perinat Epidemiol 2021; 35 (05) 596-600
  CrossrefPubMedGoogle Scholar